You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

secondary myelofibrosis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • Secondary Myelofibrosis
  • Rochester, Minnesota
    Mayo Clinic
Dec 16, 2019

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

Completed
  • Adherence, Patient
  • Adherence, Treatment
    • Cosenza, Calabria, Italy
    • +27 more
    Oct 11, 2023

    Epigenetic Age on Clinic-biological Presentation and Prognosis

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Assessment of the epigenetic age
    • Bordeaux, France
      CHU de Bordeaux, service Hématologie Biologique
    Aug 28, 2023

    Myelofibrosis Trial in Worldwide (GB2064)

    Recruiting
    • Myelofibrosis
    • Houston, Texas
    • +11 more
    Nov 23, 2022

    Ruxolitinib in Patients With Myelofibrosis

    Not yet recruiting
    • Myelofibrosis
    • (no location specified)
    Feb 28, 2023

    Myelofibrosis Trial in France (Clonal architecture determination)

    Not yet recruiting
    • Myelofibrosis
    • Clonal architecture determination
    • Angers, France
    • +6 more
    Jan 24, 2023

    Myelofibrosis Trial in Houston (CK0804)

    Not yet recruiting
    • Myelofibrosis
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Jun 28, 2022

    Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

    Recruiting
    • Myeloproliferative Neoplasm
    • +7 more
      • Hong Kong, Hong Kong
        Department of Medicine, Queen Mary Hospital
      May 21, 2023

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Myelofibrosis, Primary, Myelofibrosis, Post PV, Myelofibrosis, Post ET Trial in Zerifin (Molecular analysis)

      Unknown status
      • Myelofibrosis, Primary
      • +2 more
      • Molecular analysis
      • Zerifin, Israel
        Assaf Harofeh Medical Center
      Jul 2, 2019

      Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

      Recruiting
      • Myelofibrosis
      • +3 more
      • Anchorage, Alaska
      • +172 more
      Dec 1, 2022

      Myelofibrosis Trial in Worldwide (TL-895)

      Recruiting
      • Myelofibrosis
      • Aurora, Colorado
      • +65 more
      Jun 2, 2022

      Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (Platelet Transfusion)

      Terminated
      Has Results
      • Acute Biphenotypic Leukemia
      • +13 more
      • Platelet Transfusion
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 17, 2019

      Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)

      Active, not recruiting
      • Myelofibrosis
      • Antwerpen, Belgium
      • +11 more
      Aug 19, 2022

      Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Completed
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Phoenix, Arizona
      • +61 more
      May 5, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +125 more
      • tetanus-CMV fusion peptide vaccine
      • laboratory biomarker analysis
      • Duarte, California
        City of Hope Medical Center
      Feb 28, 2022

      Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

      Terminated
      • Essential Thrombocythemia
      • +2 more
      • Arsenic Trioxide
      • +3 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 20, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +4 more
      • Eltrombopag Olamine
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 4, 2022

      Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Terminated
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +121 more
      Oct 21, 2021

      Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

      Recruiting
      • Myelofibrosis
      • +3 more
      • Birmingham, Alabama
      • +148 more
      Oct 10, 2022

      Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

      Active, not recruiting
      • Myelofibrosis
        • Firenze, FI, Italy
        • +5 more
        Nov 11, 2021

        Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

        Active, not recruiting
        • Adult Acute Lymphoblastic Leukemia in Remission
        • +46 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Feb 10, 2021

        Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

        Recruiting
        • Myelofibrosis
        • Hematopoietic Stem Cell Transplant
        • Minneapolis, Minnesota
          Center for International Blood and Marrow Transplant Research
        Mar 17, 2022

        Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

        Completed
        Has Results
        • Primary Myelofibrosis
        • +2 more
        • Scottsdale, Arizona
        • +8 more
        Feb 10, 2022

        Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

        Completed
        Has Results
        • Myelofibrosis
        • Imetelstat 4.7 mg/kg
        • Imetelstat 9.4 mg/kg
        • Birmingham, Alabama
        • +71 more
        Aug 17, 2021